291 related articles for article (PubMed ID: 8544269)
1. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.
Hayden FG; Treanor JJ; Betts RF; Lobo M; Esinhart JD; Hussey EK
JAMA; 1996 Jan 24-31; 275(4):295-9. PubMed ID: 8544269
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
[TBL] [Abstract][Full Text] [Related]
3. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.
Hayden FG; Treanor JJ; Fritz RS; Lobo M; Betts RF; Miller M; Kinnersley N; Mills RG; Ward P; Straus SE
JAMA; 1999 Oct; 282(13):1240-6. PubMed ID: 10517426
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
Sidwell RW; Huffman JH; Barnard DL; Bailey KW; Wong MH; Morrison A; Syndergaard T; Kim CU
Antiviral Res; 1998 Feb; 37(2):107-20. PubMed ID: 9588843
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection.
Calfee DP; Peng AW; Hussey EK; Lobo M; Hayden FG
Antivir Ther; 1999; 4(3):143-9. PubMed ID: 12731753
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.
Matsumoto K; Ogawa N; Nerome K; Numazaki Y; Kawakami Y; Shirato K; Arakawa M; Kudoh S; Shimokata K; Nakajima S; Yamakido M; Kashiwagi S; Nagatake T
Antivir Ther; 1999; 4(2):61-8. PubMed ID: 10682150
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection.
Calfee DP; Peng AW; Cass LM; Lobo M; Hayden FG
Antimicrob Agents Chemother; 1999 Jul; 43(7):1616-20. PubMed ID: 10390212
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase).
Ryan DM; Ticehurst J; Dempsey MH; Penn CR
Antimicrob Agents Chemother; 1994 Oct; 38(10):2270-5. PubMed ID: 7840556
[TBL] [Abstract][Full Text] [Related]
9. Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza.
Walker JB; Hussey EK; Treanor JJ; Montalvo A; Hayden FG
J Infect Dis; 1997 Dec; 176(6):1417-22. PubMed ID: 9395349
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase inhibitors: zanamivir and oseltamivir.
McNicholl IR; McNicholl JJ
Ann Pharmacother; 2001 Jan; 35(1):57-70. PubMed ID: 11197587
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
Mäkelä MJ; Pauksens K; Rostila T; Fleming DM; Man CY; Keene ON; Webster A
J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110
[TBL] [Abstract][Full Text] [Related]
12. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.
Lancet; 1998 Dec; 352(9144):1877-81. PubMed ID: 9863784
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.
Monto AS; Fleming DM; Henry D; de Groot R; Makela M; Klein T; Elliott M; Keene ON; Man CY
J Infect Dis; 1999 Aug; 180(2):254-61. PubMed ID: 10395837
[TBL] [Abstract][Full Text] [Related]
14. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.
Gubareva LV; Robinson MJ; Bethell RC; Webster RG
J Virol; 1997 May; 71(5):3385-90. PubMed ID: 9094607
[TBL] [Abstract][Full Text] [Related]
15. Neuraminidase inhibitors for preventing and treating influenza in children.
Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A
Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931
[TBL] [Abstract][Full Text] [Related]
16. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
Monto AS; Robinson DP; Herlocher ML; Hinson JM; Elliott MJ; Crisp A
JAMA; 1999 Jul; 282(1):31-5. PubMed ID: 10404908
[TBL] [Abstract][Full Text] [Related]
17. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).
Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD002744. PubMed ID: 22513907
[TBL] [Abstract][Full Text] [Related]
18. Neuraminidase inhibitors for preventing and treating influenza in children.
Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949
[TBL] [Abstract][Full Text] [Related]
19. GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets.
Ryan DM; Ticehurst J; Dempsey MH
Antimicrob Agents Chemother; 1995 Nov; 39(11):2583-4. PubMed ID: 8585752
[TBL] [Abstract][Full Text] [Related]
20. Effect of zanamivir on duration and resolution of influenza symptoms.
Monto AS; Moult AB; Sharp SJ
Clin Ther; 2000 Nov; 22(11):1294-305. PubMed ID: 11117654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
